Image source: The Motley Fool.
Neurocrine Biosciences (NASDAQ: NBIX)
Q2 2022 Earnings Call
Aug 04, 2022 , 4:30 p.m. ET
Operator
For further details see:
Neurocrine Biosciences (NBIX) Q2 2022 Earnings Call TranscriptImage source: The Motley Fool.
Neurocrine Biosciences (NASDAQ: NBIX)
Q2 2022 Earnings Call
Aug 04, 2022 , 4:30 p.m. ET
Operator
For further details see:
Neurocrine Biosciences (NBIX) Q2 2022 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Neurocrine Biosciences Inc. Company Name:
NBIX Stock Symbol:
Market:
Neurocrine Biosciences Inc. Website:
Neurocrine Biosciences Presents CAHtalyst™ Adult Study Baseline Characteristics and Data on Impact of Supraphysiologic Glucocorticoid Therapy at AACE 2024 PR Newswire CAHtalyst™ Study Baseline Characteristics Highlight the Need for New Treatment Options to Reduce...
Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1076986 in Healthy Adults PR Newswire SAN DIEGO , May 9, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the initiation of its Pha...
Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults PR Newswire SAN DIEGO , May 8, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX), today announced the initiation of its Ph...